Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772302 · ClinicalTrials.gov registry record · NA
Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome
A NA study of Locked-in Syndrome and Consciousness Disorders, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02772302 is a NA study of Locked-in Syndrome and Consciousness Disorders that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, above the 9-participant average among 4 other Locked-in Syndrome trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02772302, a NA study of Locked-in Syndrome and Consciousness Disorders, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aims of this study are: 1. To determine the feasibility of deploying mindBEAGLE, a portable, bedside EEG-based system, in the Intensive Care Unit in patients with disorders of consciousness (DOC) or locked-in syndrome (LIS); 2. To determine if mindBEAGLE neurophysiologic markers of cognitive function correlate with bedside behavioral assessments of consciousness; 3. To determine if mindBEAGLE neurophysiologic markers of cognitive function correlate with functional MRI (fMRI) and electroencephalography (EEG) biomarkers of consciousness; 4. To determine if mindBEAGLE can serve as an assistive communication device for people with LIS.
Conditions Studied
Interventions
- DEVICE mindBEAGLE EEG-based brain-computer interface
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2019-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02772302
The ClinicalTrials.gov registry entry for NCT02772302 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 9-participant average among 4 other Locked-in Syndrome trials with a reported enrollment target (122% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Locked-in Syndrome appearing as the primary indexed condition, and to 1 intervention - of which mindBEAGLE EEG-based brain-computer interface is the first listed.
NCT02772302 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02772302 about?
NCT02772302 is a clinical study titled "Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome". The primary aims of this study are: 1. To determine the feasibility of deploying mindBEAGLE, a portable, bedside EEG-based system, in the Intensive Care Unit in patients with disorders of consciousness (DOC) or locked-in syndrome (LIS); 2. To determine if mindBEAGLE neurophysiologic markers of cogn...
What is the current status of trial NCT02772302?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-03-01. Estimated completion is 2019-12-17.
What conditions does trial NCT02772302 study?
This clinical trial studies the following conditions: Locked-in Syndrome, Consciousness Disorders.
What interventions are being tested in trial NCT02772302?
The interventions under investigation include: mindBEAGLE EEG-based brain-computer interface (DEVICE).
Who is sponsoring clinical trial NCT02772302?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02772302 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Locked-in Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Investigation on the Cortical Communication (CortiCom) System
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.